500
Participants
Start Date
March 1, 2022
Primary Completion Date
January 31, 2027
Study Completion Date
January 31, 2027
AtriCure Commercially Available Devices
Epicardial and endocardial hybrid ablation procedure used to treat the IST or POTS using AtriCure commercially available devices.
RECRUITING
MedStar Health Research Institute, Hyattsville
RECRUITING
University of Florida, Gainesville
RECRUITING
Sarasota Memorial Hospital, Sarasota
RECRUITING
The Carl & Edyth Lindner Center for Research & Education at The Christ Hospital, Cincinnati
RECRUITING
Kansas City Cardiac Arrhythmia Research, Kansas City
RECRUITING
Texas Cardiac Arrhythmia Research Foundation, Austin
RECRUITING
Intermountain Medical Center, Murray
RECRUITING
Sequoia Hospital, Redwood City
RECRUITING
Stanford University, Palo Alto
RECRUITING
Universitair Ziekenhuis Brussels, Brussels
Lead Sponsor
AtriCure, Inc.
INDUSTRY